First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Shares Down 0% – Here’s Why

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBTGet Free Report) fell 0% during mid-day trading on Wednesday . The stock traded as low as $207.86 and last traded at $208.73. 22,305 shares changed hands during mid-day trading, a decline of 88% from the average session volume of 182,409 shares. The stock had previously closed at $208.77.

First Trust NYSE Arca Biotechnology Index Fund Trading Up 1.9%

The company has a market cap of $2.37 billion, a P/E ratio of 21.72 and a beta of 0.70. The firm’s 50 day moving average price is $202.37 and its 200-day moving average price is $203.46.

Institutional Investors Weigh In On First Trust NYSE Arca Biotechnology Index Fund

Several hedge funds have recently bought and sold shares of FBT. First Trust Advisors LP raised its holdings in First Trust NYSE Arca Biotechnology Index Fund by 0.8% in the second quarter. First Trust Advisors LP now owns 8,393 shares of the company’s stock worth $1,355,000 after purchasing an additional 66 shares during the period. Baird Financial Group Inc. lifted its stake in First Trust NYSE Arca Biotechnology Index Fund by 12.9% in the second quarter. Baird Financial Group Inc. now owns 8,039 shares of the company’s stock valued at $1,297,000 after buying an additional 916 shares in the last quarter. Benjamin Edwards Inc. lifted its stake in First Trust NYSE Arca Biotechnology Index Fund by 40.5% in the second quarter. Benjamin Edwards Inc. now owns 28,808 shares of the company’s stock valued at $4,648,000 after buying an additional 8,304 shares in the last quarter. Two Sigma Securities LLC lifted its stake in First Trust NYSE Arca Biotechnology Index Fund by 56.5% in the second quarter. Two Sigma Securities LLC now owns 2,001 shares of the company’s stock valued at $323,000 after buying an additional 722 shares in the last quarter. Finally, Corient Private Wealth LLC bought a new position in First Trust NYSE Arca Biotechnology Index Fund in the second quarter valued at approximately $692,000.

About First Trust NYSE Arca Biotechnology Index Fund

(Get Free Report)

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.

See Also

Receive News & Ratings for First Trust NYSE Arca Biotechnology Index Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology Index Fund and related companies with MarketBeat.com's FREE daily email newsletter.